substance
Those Viral Bodega Peptides Aren't Actually Peptides
WIRED tested samples of four types of peptides. The results show how lightly regulated the industry is, even as popularity surges. The Mr. Green bodega sits on a busy stretch of Bedford Avenue in Brooklyn, New York. Near the counter, you can buy the usual assortment of candy, gum, rolling papers, and soda. You can also purchase tiny vials of injectable peptides .
The Great Peptide Cash Grab Has Begun
The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs. Has anyone tried to sell you peptides yet? Once a niche interest among bodybuilders and biohackers, peptides are an increasingly popular class of substance hyped by both fringe influencers and the current US Secretary of Health and Human Services. Earlier this year, Robert F. Kennedy Jr. told the podcaster Joe Rogan that the government intended to loosen restrictions on peptide production.
Robot stress test: Narwal's 1,500 mop vs. my nightmare messes
PCWorld tested the $1,500 Narwal Flow 2 robot vacuum/mop against eight challenging messes including raw egg, olive oil, coffee spills, and mud to evaluate its premium cleaning capabilities. The device excelled at tough stains by intelligently switching between vacuum and mop modes, effectively cleaning most spills with minimal residue remaining. Despite strong overall performance, the Flow 2 struggles with grout cleaning and requires weekly maintenance to prevent odors from improper drying. If a job is worth doing, it's worth doing right--and if a robot is going to clean up my place, it better do a good job. That's the stance I took when Narwal sent me its luxury Flow 2 robot vacuum/mop.
Yes, you can be allergic to water
For people with aquagenic urticaria, even a quick shower has consequences. More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. While people can be allergic to water, the condition is very rare. Only 100 to 150 cases have ever been reported. Breakthroughs, discoveries, and DIY tips sent six days a week.
The Download: OpenAI is building a fully automated researcher, and a psychedelic trial blind spot
Plus: OpenAI is also creating a super app. OpenAI has a new grand challenge: building an AI researcher--a fully automated agent-based system capable of tackling large, complex problems by itself. The San Francisco firm said the new goal will be its "north star" for the next few years. By September, the company plans to build "an autonomous AI research intern" that can take on a small number of specific research problems. The intern will be the precursor to the fully automated multi-agent system, which is slated to debut in 2028. In an exclusive interview this week, OpenAI's chief scientist, Jakub Pachocki, talked me through the plans.
Mind-altering substances are (still) falling short in clinical trials
Placebo and "knowcebo" effects are a problem. But they can also help people feel better. This week I want to look at where we are with psychedelics, the mind-altering substances that have somehow made the leap from counterculture to major focus of clinical research. Compounds like psilocybin--which is found in magic mushrooms--are being explored for all sorts of health applications, including treatments for depression, PTSD, addiction, and even obesity. Over the last decade, we've seen scientific interest in these drugs explode. But most clinical trials of psychedelics have been small and plagued by challenges.